177Lu-EB-PSMA-617 抗肿瘤前列腺癌患者的第一人研究
This first-in-human study demonstrated that 177Lu-EB-PSMA-617 had higher accumulation in mCRPC and that low imaging dose appears to be effective in treating tumors with high 68Ga-PSMA-617 uptakes.…
This first-in-human study demonstrated that 177Lu-EB-PSMA-617 had higher accumulation in mCRPC and that low imaging dose appears to be effective in treating tumors with high 68Ga-PSMA-617 uptakes.…
问问我们的产品、服务或公司 我从这个网站上回答.
答复来自该网站,可能不完整。 对话被储存起来,这样我们就可以改进它们.
